Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
Clinical trial NCT02848794 · UNKNOWN
Trial details
- NCT number
- NCT02848794
- Sponsor
- The First People's Hospital of Lianyungang
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.